Alle persberichten

Open brief aan Europa van André Rogaczewski CEO en medeoprichter van Netcompany: Europa moet voor zichzelf opkomen

In de nacht van 22 april werd het Vrijheidsbeeld bij de Pont de Grenelle in Parijs verlicht met de boodschap: “Stand Tall Europe”. Het standbeeld,...

Azizi Developments onthult Azizi Milan, de nieuwe modehoofdstad van het Midden-Oosten

De gemeenschap van 40 miljoen vierkante meter, bestaande uit 81.200 woningen, is geïnspireerd door de tijdloze schoonheid van het Italiaanse Milaan DUBAI, Verenigde Arabische Emiraten–(BUSINESS...

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

WILMINGTON, Del.–(BUSINESS WIRE)– Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its oncology portfolio will be presented at the 2025 American...

Armis lanceert de Vulnerability Intelligence Database om preventieve beveiliging te bevorderen

Het bedrijf is nu ook als CNA (CVE Numbering Authority) erkend en vervoegt deze exclusieve groep SAN FRANCISCO–(BUSINESS WIRE)– Armis, het bedrijf gespecialiseerd in cyber...

LTIMindtree’s FY25 Revenue up 7% in INR

Order Inflow at USD 6 Billion, up 6% on full-year basis MUMBAI, India–(BUSINESS WIRE)– LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital...

Next-Gen Cyber Guardians: Yubico Empowers Youth-Led Hackathons to Secure the Future

Yubico sponsored youth-led hackathons around the world foster collaboration, innovation, and hands-on cybersecurity experience for the next generation of cyber leaders SANTA CLARA, Calif. &...

Diligent Unveils AI Risk Essentials to Accelerate Risk Management and Elevate Governance

New AI-powered solution empowers organizations to identify, benchmark and mitigate risk efficiently NEW YORK–(BUSINESS WIRE)– Diligent, the leading governance, risk and compliance (GRC) SaaS company,...

Additional Keynote Speakers Announced: ISDA’s 39th Annual General Meeting in Amsterdam!

–(BUSINESS WIRE)– Join the International Swaps and Derivatives Association, Inc. (ISDA) at its 39th Annual General Meeting (AGM) in Amsterdam from Tuesday May 13 to...

Cyclic Materials to Invest Over USD $20M in its First Commercial Facility in the United States

Arizona Facility Expected to Process 25,000 Tonnes of End-of-Life Components Containing Rare Earth Permanent Magnets a Year TORONTO–(BUSINESS WIRE)– Cyclic Materials, the advanced recycling company...

GHIT Fund kent een subsidie toe voor de ontwikkeling van een ultragevoelige urinetest voor tuberculose

TOKIO–(BUSINESS WIRE)– H.U. Group Holdings, Inc. en haar dochteronderneming Fujirebio Holdings, Inc. kondigden vandaag aan dat de Global Health Innovative Technology (GHIT) Fund aan Fluxus,...

euNetworks Appoints Marisa Trisolino as Chief Executive Officer

Marisa Trisolino joins the business on 12 May 2025 Interim CEO Kevin Dean transitions to Chairman of euNetworks LONDON–(BUSINESS WIRE)– euNetworks Group Limited (“euNetworks”), a...

Armis Launches Vulnerability Intelligence Database to Enhance Preemptive Security

Company also now authorized as a CVE Numbering Authority, joining exclusive group SAN FRANCISCO–(BUSINESS WIRE)– Armis, the cyber exposure management & security company, today announced...

Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis

TOKYO–(BUSINESS WIRE)– H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded...

QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis

TAIPEI, Taiwan–(BUSINESS WIRE)– QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion...

Imricor begint VISABL-VT-onderzoek

MINNEAPOLIS–(BUSINESS WIRE)– Imricor Medical Systems, Inc. ( Bedrijf of Imricor ) ( ASX: IMR ) kondigt verheugd aan dat het begint met de VISABL-VT klinische...